House to vote today on FDA user fee bill

It's now the House's turn. U.S. House Republicans are expected to vote today on the FDA user fee bill, and Politico predicts the bill will sail through without any problems.

Meanwhile, the Consumers Union is sounding the alarm, claiming that the House bill is weaker than what the Senate passed just last week. They want the House bill to make it easier for the FDA to reclassify problematic devices so related ones are looked at more rigorously before approval. Also needed, according the group, is a time frame for imposing proposed regulations on unique device identifiers.

They criticize each version of the bill for lacking "critical patient safety protections." But the industry has supported both as keeping regulatory standards high but also making the approval process less cumbersome.

Device industry group AdvaMed lauded the Senate bill as striking a valid balance between the needs of regulators, industry and patients. Device approval fees will more than double over the life of the new agreement, reaching $609 million before it expires in 2017. He said the measure will help make the regulatory process more predictable and consistent and keep approval standards "stringent."

- read the Politico item
- here's the Consumers Union release

Suggested Articles

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.

Philips looked back on 15 years of data from one of its telehealth-equipped intensive care units, where centralizing operations reduced mortality.

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.